Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations
0.1.0 - ci-build
Uzbekistan Digital Health Platform - Integrations - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://terminology.dhp.uz/fhir/integrations/ValueSet/dhis-observation-component-code-vs | Version: 0.1.0 | ||||
| Draft as of 2026-07-13 | Computable Name: DHISObservationComponentCodeVS | ||||
Value set of tuberculosis observation component codes. Plain drug-name DST agents use their LOINC [Susceptibility] code directly; concentration-bearing agents and non-drug component codes use local codes from the DHIS observation component code system.
References
Language: uz
This value set includes codes based on the following rules:
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs version 📍0.1.0| Code | Display |
| tub004-0001 | INH ↑ MIK natijasi |
| tub004-0002 | INH ↓ MIK / ETH natijasi |
| tub004-0003 | FQL ↑ MIK natijasi |
| tub004-0004 | FQL ↓ MIK natijasi |
| tub004-0005 | AMK/KAN/CAP natijasi |
| tub004-0006 | AMK/KAN natijasi |
| tub004-0007 | Rifampitsin (1,0 mg/ml) |
| tub004-0008 | Izoniazid (0,1 mg/ml) |
| tub004-0009 | Etambutol (5,0 mg/ml) |
| tub004-0010 | Pirazinamid (100 mg/ml) |
| tub004-0011 | Levofloksatsin (2,0 mg/ml) |
| tub004-0012 | Moksifloksatsin (1,0 mg/ml) |
| tub004-0013 | Moksifloksatsin (0,25 mg/ml) |
| tub004-0014 | Gatifloksatsin (0,25 mg/ml) |
| tub004-0015 | Amikatsin (1,0 mg/ml) |
| tub004-0016 | Protionamid (2,5 mg/ml) |
| tub004-0017 | Linezolid (1,0 mg/ml) |
| tub004-0018 | Klofazimin (1,0 mg/ml) |
| tub004-0019 | Bedaquilin (1,0 mg/ml) |
| tub004-0020 | Delamanid (0,06 mg/ml) |
| tub004-0021 | Pretomanid (1,0 mg/ml) |
| tub004-0023 | Isoniazid ↑MIC |
| tub004-0024 | Isoniazid ↓MIC |
| tub004-0025 | Ethionamide-Prothionamide |
| tub004-0026 | Moxifloxacin ↑MIC |
| tub004-0027 | Moxifloxacin ↓MIC |
| tub004-0031 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0032 | Gradatsiya |
| tub004-0033 | Kultura identifikatsiyasi |
| tub004-0034 | M. tuberculosis complex aniqlash natijasi |
| tub004-0035 | CM/AS izolyatini identifikatsiya qilish |
| tub004-0036 | ARVT (Antiretrovirusli terapiya) |
| tub004-0037 | KTR boshlandi |
http://loinc.org version Not Stated (use latest from terminology server)
| Code | Display |
| 18974-6 | rifAMPin [Susceptibility] |
| 20629-2 | levoFLOXacin [Susceptibility] |
| 18860-7 | Amikacin [Susceptibility] |
| 18935-7 | Kanamycin [Susceptibility] |
Expansion from tx.fhir.org based on:
This value set contains 37 concepts
| System | Code | Display (uz) - uz | JSON | XML |
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0001 | INH high MIC result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0002 | INH low MIC / ETH result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0003 | FQL high MIC result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0004 | FQL low MIC result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0005 | AMK/KAN/CAP result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0006 | AMK/KAN result | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0007 | Rifampicin (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0008 | Isoniazid (0.1 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0009 | Ethambutol (5.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0010 | Pyrazinamide (100 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0011 | Levofloxacin (2.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0012 | Moxifloxacin (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0013 | Moxifloxacin (0.25 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0014 | Gatifloxacin (0.25 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0015 | Amikacin (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0016 | Prothionamide (2.5 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0017 | Linezolid (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0018 | Clofazimine (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0019 | Bedaquiline (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0020 | Delamanid (0.06 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0021 | Pretomanid (1.0 mg/mL) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0023 | Isoniazid ↑MIC | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0024 | Isoniazid ↓MIC | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0025 | Ethionamide-Prothionamide | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0026 | Moxifloxacin ↑MIC | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0027 | Moxifloxacin ↓MIC | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0031 | CM/AS isolate identification | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0032 | Grading | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0033 | Culture identification | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0034 | Result of M. tuberculosis complex detection | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0035 | CM/AS isolate identification | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0036 | ART (Antiretroviral Therapy) | ||
https://terminology.dhp.uz/fhir/integrations/CodeSystem/dhis-observation-component-code-cs | tub004-0037 | KTR begin | ||
http://loinc.org | 18974-6 | rifAMPin [Susceptibility] | ||
http://loinc.org | 20629-2 | levoFLOXacin [Susceptibility] | ||
http://loinc.org | 18860-7 | Amikacin [Susceptibility] | ||
http://loinc.org | 18935-7 | Kanamycin [Susceptibility] |